|
|
Gene Symbol |
PIK3CA |
|
Aliases |
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha |
|
Entrez Gene ID |
|
|
Gene Name |
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
|
Chromosomal Location |
3q26.32 |
|
HGNC ID |
|
|
Summary |
Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001944 |
Biological process |
Vasculature development |
TAS |
19200708 |
GO:0014065 |
Biological process |
Phosphatidylinositol 3-kinase signaling |
IBA |
21873635 |
GO:0016242 |
Biological process |
Negative regulation of macroautophagy |
NAS |
23778976 |
GO:0016310 |
Biological process |
Phosphorylation |
IDA |
25327288 |
GO:0016477 |
Biological process |
Cell migration |
IBA |
21873635 |
GO:0030168 |
Biological process |
Platelet activation |
TAS |
21035500 |
GO:0032008 |
Biological process |
Positive regulation of TOR signaling |
NAS |
23778976 |
GO:0036092 |
Biological process |
Phosphatidylinositol-3-phosphate biosynthetic process |
IBA |
21873635 |
GO:0038028 |
Biological process |
Insulin receptor signaling pathway via phosphatidylinositol 3-kinase |
TAS |
19200708 |
GO:0043276 |
Biological process |
Anoikis |
NAS |
23778976 |
GO:0043542 |
Biological process |
Endothelial cell migration |
TAS |
19200708 |
GO:0046854 |
Biological process |
Phosphatidylinositol phosphorylation |
IBA |
21873635 |
GO:0048015 |
Biological process |
Phosphatidylinositol-mediated signaling |
IBA |
21873635 |
GO:0060048 |
Biological process |
Cardiac muscle contraction |
TAS |
19147653 |
GO:2000811 |
Biological process |
Negative regulation of anoikis |
IMP |
22402981 |
GO:0005737 |
Cellular component |
Cytoplasm |
IBA |
21873635 |
GO:0005886 |
Cellular component |
Plasma membrane |
IBA |
21873635 |
GO:0005942 |
Cellular component |
Phosphatidylinositol 3-kinase complex |
IBA |
21873635 |
GO:0005943 |
Cellular component |
Phosphatidylinositol 3-kinase complex, class IA |
IBA |
21873635 |
GO:0005943 |
Cellular component |
Phosphatidylinositol 3-kinase complex, class IA |
IDA |
22402981 |
GO:0016020 |
Cellular component |
Membrane |
IBA |
21873635 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
10490823, 16043515, 17475214, 19411071, 19574958, 19805105, 20018188, 20713702, 22402981, 23643389, 23676467, 24189400, 25253337, 25814554, 26496610 |
GO:0016301 |
Molecular function |
Kinase activity |
IDA |
25327288 |
GO:0016303 |
Molecular function |
1-phosphatidylinositol-3-kinase activity |
IBA |
21873635 |
GO:0016303 |
Molecular function |
1-phosphatidylinositol-3-kinase activity |
IDA |
2174051 |
GO:0035004 |
Molecular function |
Phosphatidylinositol 3-kinase activity |
TAS |
19200708 |
GO:0035005 |
Molecular function |
1-phosphatidylinositol-4-phosphate 3-kinase activity |
IBA |
21873635 |
GO:0046934 |
Molecular function |
Phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
IBA |
21873635 |
|
Protein Information |
|
Protein Name |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PI3-kinase p110 subunit alpha, phosphatidylinositol 3-kinase, catalytic, 110-KD, alpha, phosphatidylinositol 3-kinase, catalytic, alpha polypeptide, phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, alpha isoform, phosphoinositide-3-kinase, catalytic, alpha polypeptide, ptdIns-3-kinase subunit p110-alpha, serine/threonine protein kinase PIK3CA |
|
Function |
Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns (Phosphatidylinositol), PtdIns4P (Phosphatidylinositol 4-phosphate) and PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. Also has serine-protein kinase activity: phosphorylates PIK3R1 (p85alpha regulatory subunit), EIF4EBP1 and HRAS. Plays a role in the positive regulation of phagocytosis and pinocytosis (By similarity). |
|
|
|
|
|
UniProt |
|
|
PDB |
2RD0, 3HHM, 3HIZ, 4JPS, 4L1B, 4L23, 4L2Y, 4OVU, 4OVV, 4WAF, 4YKN, 4ZOP, 5FI4, 5ITD, 5SW8, 5SWG, 5SWO, 5SWP, 5SWR, 5SWT, 5SX8, 5SX9, 5SXA, 5SXB, 5SXC, 5SXD, 5SXE, 5SXF, 5SXI, 5SXJ, 5SXK, 5UK8, 5UKJ, 5UL1, 5XGH, 5XGI, 5XGJ, 6NCT, 2ENQ, 3ZIM, 4TUU, 4TV3, 5DXH, 5DXT, 5UBR |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000263054 |
|
|
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Hereditary hemorrhagic telangiectasia |
|
Genetic Diseases |
17376864, 16847462, 26301495, 22729224, 24497998, 27426476, 25557259, 27870750, 27631024, 23246288, 23754335, 28941273, 22228622, 26593112 |
Megalencephaly-Capillary Malformation (MCAP) Syndrome |
|
Cortical Dysplasia |
|
Macrodactyly of the foot |
|
Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome |
|
Fetal Alcohol Syndrome |
|
Malformations of Cortical Development |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Liver Cancer |
|
Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi |
|
Hepatoblastoma |
|
Mouth Neoplasms |
|
Breast Cancer |
15254419, 21558396, 26619011, 18725974, 22162582, 25157968, 22162589, 18676830, 23888070, 15805248, 15647370, 20453058, 19196980, 25358515, 19685490, 21633166, 26587011, 22370636, 20479250, 25267515, 16353168, 22729223, 22729224, 15520168, 15016963, 17673550, 22729222, 15608678, 22658544 |
Stomach Cancer |
|
Lung Cancer |
25157968, 22658544, 15254419, 22162589, 24033266, 20453058, 19513541, 15647370, 15520168, 15608678, 19029981, 21430269, 16906227, 22729222, 22729223, 22729224, 15016963, 17673550, 18725974, 26619011, 22135231 |
Renal Cancer |
|
Ovarian Cancer |
18183466, 16353168, 24033266, 15016963, 19671852, 18371219, 15520168, 20177704, 17673550, 22729223, 15608678, 22729224, 22658544, 22729222, 26619011 |
Colorectal Cancer |
15930273, 15994075, 25157968, 19223544, 15254419, 22357840, 22162589, 26619011, 19903786, 19366826, 24559322, 20619739, 18725974, 15016963, 15647370, 22162582, 20453058 |
PTEN Hamartoma Tumor Syndrome |
|
Adenocarcinoma of Prostate |
|
Neuroblastoma |
|
Nasopharyngeal Cancer |
|
Colonic Neoplasms |
|
Lymphoma |
|
Head and Neck Neoplasms |
|
Rosette-forming glioneuronal tumor |
|
Head Neoplasms |
|
Adenocarcinoma |
|
Carcinoma |
|
Sarcoma |
|
Cribriform Carcinoma |
|
Epidermal nevus |
|
Brain Neoplasms |
|
Multiple Myeloma |
|
Adenoid Cystic Carcinoma |
|
Prostate cancer |
|
Endometrial Cancer |
|
Thyroid Cancer |
|
Glioblastoma |
|
Gall Bladder Cancer |
|
Brain Stem Glioma |
|
Adrenal Cancer |
|
Bladder Cancer |
|
Esophagus Neoplasm |
|
Breast Cancer,Male |
|
Hamartoma |
|
Genital Neoplasms, Male |
|
Intestinal Cancer |
|
Ctaneous Melanoma |
|
Gastric Cancer |
|
Adenocarcinoma Of Pancreas |
|
Medulloblastoma |
|
Vulvar Cancer |
|
Nervous System Diseases |
Stroke |
|
Hydrocephalus |
|
Psychiatric/Brain disorders |
Schizophrenia |
|
Skin and Connective Tissue Diseases |
Keratosis |
|
|
References |
|
|
Das Debabrata, Arur Swathi |
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.| Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
Mol Reprod Dev. 2017 Jun;84(6):444-459. doi: 10.1002/mrd.22806. Epub 2017 Apr 24. |
Abstract
Insulin signaling regulates various aspects of physiology, such as glucose homeostasis and aging, and is a key determinant of female reproduction in metazoans. That insulin signaling is crucial for female reproductive health is clear from clinical data linking hyperinsulinemic and hypoinsulinemic condition with certain types of ovarian dysfunction, such as altered steroidogenesis, polycystic ovary syndrome, and infertility. Thus, understanding the signaling mechanisms that underlie the control of insulin-mediated ovarian development is important for the accurate diagnosis of and intervention for female infertility. Studies of invertebrate and vertebrate model systems have revealed the molecular determinants that transduce insulin signaling as well as which biological processes are regulated by the insulin-signaling pathway. The molecular determinants of the insulin-signaling pathway, from the insulin receptor to its downstream signaling components, are structurally and functionally conserved across evolution, from worms to mammals-yet, physiological differences in signaling still exist. Insulin signaling acts cooperatively with gonadotropins in mammals and lower vertebrates to mediate various aspects of ovarian development, mainly owing to evolution of the endocrine system in vertebrates. In contrast, insulin signaling in Drosophila and Caenorhabditis elegans directly regulates oocyte growth and maturation. In this review, we compare and contrast insulin-mediated regulation of ovarian functions in mammals, lower vertebrates, C. elegans, and Drosophila, and highlight conserved signaling pathways and regulatory mechanisms in general while illustrating insulin's unique role in specific reproductive processes. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|